Player

Science and Technology Committee

Tuesday 17 October 2017 Meeting started at 10.06am, ended 12.53pm

Share



You can find out more information and instructions on our Help page.

Select a section of the video and receive a download link via email.

Please read and agree to the following terms and conditions before continuing.

Use of audio-visual recordings of parliamentary proceedings

This material is published on parliamentlive.tv tv with the authority of the House of Commons and/or the House of Lords. It is protected by parliamentary copyright and all rights are reserved.

You are permitted to reproduce this material only if you comply with the Terms and Conditions.

In particular you may not:

  • alter the video or audio of the recording in any way;
  • use this material for satire, advertising, entertainment content or productions or to suggest endorsement; or
  • use this material on websites or social media platforms that promote, encourage or facilitate illegal activity, encourage hatred or anti-social behaviour.

Parliamentary privilege protects freedom of speech during parliamentary proceedings. Please be aware that republishing footage of those proceedings is unlikely to be protected. If you choose to republish this material, you do so at your own discretion and risk.

Reasonable care has been taken to make sure that this material and any related software code contains no errors, viruses, or defects, but no warranty is given that this is the case.

By clicking ‘continue’ you acknowledge that you have read and understood the Terms and Conditions and agree to be bound by them.


Unfortunately, it is not currently possible to save parliamentlive.tv downloads on an iOS device (e.g. Apple iPhones, iPads).


You can find out more information and instructions on our Help page.

Channel:
9

House:
Lords

Location:
Committee room 4a

Event Type:
Select committee

Production:
TV
  • Subject: Life Sciences and the Industrial Strategy

  • Witness(es): Mr Dave Allen, Senior Vice President Respiratory Disease R&D, GSK Mr Menelas Pangalos, Executive Vice-President of Innovative Medicines and Early Development (IMED) Biotech Unit, AstraZeneca

  • Witness(es): Mr Bryn Sage, Chief Executive, Inhealthcare Ltd, Mark Campbell CBE, Senior Manager, Randox Laboratories Ltd and Ian Staples, Chief Executive, Matoke Holdings Ltd.

  • Witness(es): Sir Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence Dr Ian Hudson, Chief Executive, Medicines and Healthcare Products Regulatory Agency

  • 10:06:53

    Subject: Life Sciences and the Industrial Strategy

  • 10:06:54

    Witness(es): Mr Dave Allen, Senior Vice President Respiratory Disease R&D, GSK Mr Menelas Pangalos, Executive Vice-President of Innovative Medicines and Early Development (IMED) Biotech Unit, AstraZeneca

  • 11:03:22

    Witness(es): Mr Bryn Sage, Chief Executive, Inhealthcare Ltd, Mark Campbell CBE, Senior Manager, Randox Laboratories Ltd and Ian Staples, Chief Executive, Matoke Holdings Ltd.

  • 11:51:28

    Witness(es): Sir Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence Dr Ian Hudson, Chief Executive, Medicines and Healthcare Products Regulatory Agency